Anna Kazanchyan, Director at Foamix Pharmaceuticals Ltd. (FOMX), sold 10,600 shares at $2.61 ($28K) on 2019-05-20, disclosed to the SEC on 2019-05-20.
Open-market sale of $28k FOMX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |